Since c-Met has an important role in the development of cancer, it is considered as an attractive target for cancer therapy. Although molecular mechanisms for oncogenic property of c-Met have been actively investigated, regulatory elements for c-Met endocytosis and its effect on c-Met signaling remain unclear. In this study, we identified a pivotal endocytic motif in c-Met and tested it for selective modulation of HGF-induced c-Met response. Using various chimeric constructs with the cytoplasmic tail of c-Met, we were able to demonstrate that a dileucine motif located in the C-terminus of c-Met acts to regulate its endocytosis. Synthetic peptide Ant-3S, consisting of antennapedia-derived protein transduction domain (designated as Ant) and c-Met-derived 16 amino-acids (designated as 3S, spanning amino-acids 1378 to 1393), rapidly moved into cancer cells and disrupted c-Met trafficking. Importantly, an extension of c-Met retention time on the membrane by Ant-3S peptide significantly decreased phosphorylation-dependent c-Met signal transduction. Additionally, the peptide effectively inhibited HGF-induced cell growth, scattering and migration. The underlying molecular mechanism for these observations has been investigated and revealed that the dileucine motif interacts with endocytic machinery, including adaptin b and caveolin-1, for sustained and enhanced signal transduction. Finally, Ant-3S peptide specifically blocked internalization of interleukin-2 receptor a-subunit/3S chimeric protein, but not the other receptors, including Glut4, Glut8 and transferrin receptor. Such results indicate the presence of a selective endocytic assembly for c-Met. It also suggests a potential for c-Met-specific anti-cancer therapy using the identified endocytic motif in this study.
INTRODUCTION
Endocytosis of receptors in response to ligands affects cellular physiology; receptor trafficking rate determines the duration and propagation of signal transduction and further regulates cell growth, motility and even the fate. 1 Therefore, finding out how receptor trafficking is fine-tuned, and applying such knowledge on molecular mechanisms of endocytosis may give way to control cellular biological processes.
C-Met is an attractive target for cancer therapy owing to its significant role in the development of cancer. Thus, there have been thorough investigations on the underlying mechanisms for c-Met-driven malignancy in various cancer cells. However, there are still unsolved questions related to c-Met endocytosis and its effect on downstream signaling. A series of reports suggests the presence of distinct trans-acting molecular mediators for c-Met internalization, including PKC, 2, 3 Cbl, 4 clathrin, 5 dynamin 2 6 and small G proteins such as Rho, Rac and Rab. 7 However, there is a controversy concerning cis-acting regulatory elements for c-Met trafficking. Peschard et al. 8 demonstrated that Y1003 is required for the recruitment of c-Cbl and subsequent ubiquitination of c-Met, and Petrelli et al. 4 reported that HGF-dependent internalization of c-Met is mediated by endophilin-CIN85-Cbl complex.
But Abella et al. 9 demonstrated that Y1003F Met mutant lacking Cbl-docking site exhibited HGF-induced internalization similar to its wild type, implying that Y1003 may not be the prime determinant of c-Met endocytosis.
Endocytosis is a series of simultaneous micro-reactions that involves clathrin, adaptors and numerous different accessory proteins. 10 The endocytic trafficking of receptor is mediated by two types of pathway: clathrin-mediated pathway and clathrinindependent pathway. 11 For clathrin-coated vesicles to form, several types of adaptor and accessory molecules need to be localized between the vesicles and plasma membrane surface. During coat assembly, the adaptor proteins selectively bind to the cargo receptors by recognizing specific motifs located in the cytoplasmic tail of receptors. Among several docking motifs for adaptors, the conserved dileucine motif is a well-characterized binding moiety for clathrin and AP-2-dependent endocytosis. 12--15 Interestingly, such a putative dileucine motif is located in the C-terminus of c-Met and is conserved among the species, including human, rat, gallus and xenopus. This prompted our curiosity: Is this dilucine residue a crucial motif for c-Met trafficking? We tried to find an answer to this question by means of chimeric fusion proteins and point mutations. Moreover, we confirmed our data by using a synthetic peptide that consists of a dileucine-containing C-terminal region of c-Met and protein transduction domain (PTD).
Protein transduction domain was first identified during research on the spontaneous entry process of TAT, which enters into the nucleus and transactivates the viral long-terminal repeat promoter. 16 Further studies demonstrated that the spanning amino-acids 47--57 are the minimum sequence required for transduction. 17 Similar studies were performed on antennapedia, Drosophila homeodomain transcription factor. Derossi et al. revealed that a 16 amino-acids sequence spanning from 43 to 58 is required for best membrane transduction. 18--20 Since then, several different types of peptides that were shown to rapidly translocate to the plasma membrane have been identified and applied to conjugation and delivery of biological cargos. For peptide delivery, both antennapedia-derived peptide and TAT-derived peptide have been employed and those conjugates effectively attenuated protein--protein and enzyme--substrate interactions related to growth factor, integrin signaling, apoptosis and cell division. 21 In this study, we identified the pivotal endocytic motif for c-Met trafficking using several chimeric fusion proteins consisting of the non-endocytic extracellular domain of interleukin-2 receptor a-subunit (IL2RA) and cytoplasmic tail of c-Met. Also, we designed a peptide that can enter into the cells and compete with endogenous c-Met for endocytosis. The synthetic peptide was shown to move across the plasma membrane and to significantly inhibit endocytosis, phosphorylation and downstream signaling of endogenous c-Met so that the migration and growth of cancer cells were inhibited. More importantly, we identified a selective inhibitory property of Ant-3S peptide in c-Met endocytosis. Our findings suggest that the targeted inhibition of endocytic motif in c-Met could well be one of the effective strategies towards the development of clinical therapeutics for cancer treatment.
RESULTS
A critical role of C-terminal dileucine motif in c-Met trafficking PSLL motif in the cytoplasmic tail of GLUT4 has an essential role in its endocytic trafficking. 22 PSLL sequence is also located in the C-terminus of c-Met and is conserved among several species (Figure 1a ), prompting our curiosity to examine if it would be functional in c-Met trafficking. First, we made several DNA constructs shown in Figure 1b . To trace endocytic trafficking, we designed chimeric fusion proteins consisting of the extracellular domain of IL2RA and cytoplasmic domains of c-Met. As a positive control, we used the cytoplasmic domain of disks large homolog 4, which contains the endocytic motif in its C-terminus. 23 Upon transient introduction of those DNA in COS-7, endocytosis was induced by transferring cells from 4 to 37 1C, and we observed subcellular distribution of the chimeric fusion proteins by immunofluorescence microscopy. The green fluorescence represents the cell surface IL2RA, whereas the red fluorescence shows the intracellular IL2RA with the partial surface one (see the section Statistical analysis of immunofluorescence images in Materials and methods). As shown in Figure 1c , more than 61% of IL2RA extracellular domain chimeras were localized on the cell surface until 120 min, whereas 60% of IL2RA or disks large homolog 4 proteins were internalized, forming endocytic vesicles and localized in the perinuclear region since 10 min. About 70% of chimeras were endocytosed in the case of IL2RA/c-Met 1343À1408 , which contains the cytoplasmic domain from 1343 to 1408 of c-Met. IL2RA/c-Met 1363À1408 with a shorter cytoplasmic domain and even IL2RA/3S with 16 amino acids showed rapid internalization. We designated the 16 amino acids as the 3S region because of the three serine amino acids. When dileucine was mutated into dialanine, endocytosis of chimeric fusion protein was significantly inhibited. Taken together, dileucine located in the 3S region is a critical motif for endocytic trafficking of c-Met. Quantification of endocytosis is shown in Figure 1d . Endocytic kinetics of IL2RA/ 3S-LL/AA was shown to be similar to those of IL2RA or the extracellular domain.
Trafficking of IL2RA/3S chimeric fusion protein Previous studies demonstrated that c-Met is internalized through clathrin-mediated pathway. 5 To demonstrate that 3S region is the key signal that regulates endocytic sorting of c-Met, we examined whether IL2RA/3S is internalized through a clathrin-mediated pathway like c-Met. When clathrin-coated pits are formed, dynamin pinches off them so that the vesicles move inwards. 24 This means that Dynasore, an inhibitor of dynamin, blocks clathrin-mediated endocytosis. As shown in Figure 2a , endocytosis of IL2RA/3S was inhibited by Dynasore, which suggests that endocytosis of IL2RA/3S is mediated by clathrin, just like its fulllength protein c-Met. In addition, internalization of IL2RA/3S was also inhibited by ConA, which perturbs endocytic machinery, even though its mechanism of action is different from those of Dynasore. K252a, a potent inhibitor for receptor tyrosine kinases of the Trk family, did not show any inhibitory effect on endocytosis of IL2RA/3S. Vinblastine, which disrupts microtubule network, did not inhibit the endocytosis of IL2RA/3S, but was able to significantly block the transportation of the chimera to the perinuclear region, which indicates that IL2RA/3S traffic also requires microtubule-dependent movement just like its original protein, c-Met 25 ( Figures 2a and b) . Quantification of IL2RA/3S endocytosis is shown in Figure 2c .
Interaction of dileucine motif with b-adaptin During the assembly of clathrin-coated vesicle, various adaptins specifically bind to cargo receptor by recognizing specific motifs of the cargo's cytoplasmic tail. An adaptin b2, a subunit of AP2 complex, which regulates the plasma membrane to the trans-golgi trafficking, is an example that recognizes C-terminal dileucine motif of GLUT8 during its endocytic-vesicle formation. 12 We were curious regarding the interaction of adaptin proteins with the C-terminal dileucine motif of c-Met. In co-immunoprecipitation experiment, interaction of adaptin b1/2 with IL2RA/3S was observed, but binding was interrupted when dileucine motif was replaced by dialanine (Figure 2d ), suggesting that dileucine motif is crucial for interaction with adaptin b1/2. In addition, the full-length c-Met was co-localized with adaptin b, but not with adaptin a (Figure 2e ).
Delivery of 3S-derived synthetic peptide into cells and its effects on Met trafficking Based on our previous data, we tried to find a way to modulate Met trafficking by applying our discovery that 3S region with dilucine motif is a critical element for Met endocytosis. In this regard, we devised a peptide that was able to inhibit the interaction between Met and putative endocytic machineries by competing with endogenous Met in the cytoplasm. As shown in Figure 3a , we designed a synthetic peptide, which constists of PTD, 3S region of c-Met and FITC. The PTD, which functions in delivering peptide into the cells, was derived from antennapedia, Drosophila homeodomain transcription factor, spanning aminoacids 43 to 58 26 whereas 3S region which competitively inhibits c-Met endocytosis was originated from C-terminus of c-Met, spanning amino-acids 1378 to 1393. The reason why we chose c-Met-derived 16 mer residues was to ensure the specificity of the peptide. To be specific, a peptide containing just the dileucine motif has a comparatively broader specificity. 15 In other words, residues surrounding the motif have a key role in specific protein interactions by affecting the binding affinity. 15, 27, 28 According to Stein et al., 27 the context, referring to residues surrounding the motif, contributes to the binding energy at about 21.1% on an average, and the mean length of the context was about 5.5 residues. Therefore, six residues were included on both sides of PSLL to ensure specific inhibition of c-Met endocytosis. To detect the peptide in the subcellular region, FITC was conjugated to its C-terminus. We designated this peptide as Ant-3S-FITC. As introduction of antennapedia-derived PTD domain to the N-terminus of cargo enables the cargo to move across the plasma membrane, 26 we tested whether the synthetic peptide was able to travel effectively to the intracellular region. Using flow-cytometry analysis, we observed that the mean fluorescence intensity increased in a dose-dependent and time-dependent manner ( Figures 3b--e) . Also, we confirmed the cell-penetrating property of Ant-3S peptide at various cell densities by immunocytochemistry ( Figure 3f ). Next, we examined the effect of peptide on c-Met internalization. Generally, endocytosis is inhibited at 4 1C with receptors located in the cell surface, and internalized again when the cells are placed at 37 1C for the second time. We found that c-Met also responds and internalizes by temperature-dependent endocytosis through the flow-cytometry study (Figure 3g ). Cells were therefore pre-incubated with Ant-3S peptide, placed at 4 1C and then transferred at 37 1C again, allowing c-Met to be endocytosed in a temperature-dependent manner. As shown in Figure 3g peptide blocked the temperature-dependent endocytosis of c-Met, whereas the surface expression of c-Met was significantly decreased when vehicle was treated. Then, we wondered what would happen with the trafficking of activated c-Met after peptide treatment? Binding of HGF to c-Met induces autophosphorylation of c-Met and the activation of downstream signaling. 29 In active form, the phosphorylated c-Met is detected in endocytic vesicles, activating STAT-3. 25 To investigate whether Ant-3S peptide could inhibit endocytosis of c-Met in active form, we studied the cellular distribution of its phosphorylated form after the treatment of peptide. As shown in Figure 3h , HGF-induced formation of endocytic vesicles containing p-Met was significantly disrupted by 10 mM Ant-3S peptide, indicating that 3S containing a dileucine motif regulates HGF-dependent internalization of the active c-Met. In addition, our result indicates that the concentration of Ant-3S peptide determines its transportation rate to the perinuclear region; at a low concentration and the translocation from cytoplasm to the perinuclear region was significantly delayed in comparison to those at high concentration. These results suggest that the high concentration of Ant-3S peptide or a large amount of activated Met accelerate and stabilize their interactions with adaptins and accessory molecules so that they move efficiently to the perinuclear region.
Inhibition of HGF-dependent c-Met signaling activation and migration by Ant-3S peptide C-terminal phosphorylation of receptor is closely related to its endocytosis in some cases. As it concerns EGFR, phosphorylations of C-terminus are implicated in the regulation of its endocytosis. 30 The endocytosis of transferrin receptor however, does not require phosphorylation on its cytoplasmic tail. 31 So, what about the relationship between phosphorylation and endocytosis of c-Met? Li et al. Figure 4a , Ant-3S peptide potently decreased HGF-induced Met phosphorylation not in entirety but in a dose-dependent manner, revealing that the phosphorylation of c-Met is dependent on its endocytosis to some extent. In other words, c-Met internalization should be preceded for its complete phosphorylation.
To investigate the effects of Ant-3S peptide on c-Met downstream signaling, we performed western blotting of signaling proteins. As shown in Figure 4b , Ant-3S peptide decreased HGF-induced Erk1/2 phosphorylation and its inhibitory effect was competitive in comparison with other inhibitors including PHA-665752, Wortmannin, Dynasore and GM6001 (Figure 4c ). Consistent with this was the diminishment of HGF-dependent proliferation of Hep3B by Ant-3S peptide (Figure 4d ). On top of this, HGF-induced wound healing of Hep3B, scattering of MDCK and migration of Hep3B, and human umbilical vein endothelial cells were significantly inhibited by Ant-3S peptide (Figures 4e--g ).
Then, we wondered, how Ant-3S peptide could block the HGFinduced endocytosis of c-Met. Petrelli et al. 4 demonstrated that the ligand-dependent internalization of c-Met was mediated by the endophilin-CIN85-Cbl complex. Therefore, we proposed that Ant-3S peptide may inhibit the association of c-Met and endophilin-CIN85-Cbl complex. The association, however, was found undisrupted by Ant-3S peptide (Figure 4i) . Instead, the interaction of adaptin b1/2 with c-Met was found to be weakened as consistent with previous co-immunoprecipitation data (Figure 2d ). Interestingly, Ant-3S peptide was found to significantly disrupt the HGF-induced association of c-Met and caveolin-1 (Figure 4i ). According to Cantiani et al., 32 c-Met was co-localized with caveolin-1 at the cell surface of osteosarcoma. To confirm such an observation, immunocytochemistry study was performed and the result indicated that the internalized c-Met was co-localized with caveolin-1 in the endocytic vesicles (Figure 4j ). It can thus be perceived that Ant-3S peptide decreases the biological activity of c-Met by disrupting the association of c-Met and the endocytic machineries including adaptin b1/2 and caveolin-1.
The specific inhibition of c-Met-derived endocytic motif by Ant-3S-peptide Previous data demonstrated that the Ant-3S-peptide is able to inhibit endocytosis of c-Met. We wondered if the peptide specifically blocks the endocytosis of c-Met or if it also inhibits the internalization of other receptors. To address this, effects of the peptide on other receptors were tested under immunofluorescence microscopy. Amino-acid sequences of different kinds of endocytic motifs derived from c-Met, Glut4, Glut8 and transferrin receptor are shown in Figure 5a . Like c-Met, GLUT4 and GLUT8 also contain a dilucine motif in their cytoplasmic tail and transferrin receptor has a YTRF motif for its endosomal recycling. As a consequence of temperature-induced endocytosis, the Ant-3S-peptide was unable to block the endocytosis of Glut4, Glut8 and transferrin receptor, whereas internalization of IL2RA/3S was selectively inhibited (Figure 5b ). Such a result suggests that targeted inhibition of the 3S region can be a basis for c-Metspecific modulation of cancer.
DISCUSSION
Receptor-mediated endocytosis has several functions. Transmembrane signal transduction induced by external ligands can be downregulated by endocytosis, followed by lysosomal or proteosomal degradation. 33 Such a function is important for preventing cells from transforming to cancerous cells by inhibiting overstimulation of external growth signals. 34 On the contrary, endocytosis mediates effective signal transduction from cell periphery to the nucleus; a series of reports suggest that endosomal trafficking functions as signaling platforms for sustained duration and intensity of signaling. 35 In this regard, there are still controversies on whether or not endocytosis of c-Met enhances the signal transduction. Petrelli et al. 4 showed that the perturbation of c-Met endocytosis by ectopic expression of dominant interfering mutants of Cbl, CIN85 and endophilin sustained and promoted the c-Met activation and its biological activity. We also impaired the c-Met internalization by using the 3S peptide, but the result was in contrary; a prolongation of the retention time of c-Met on membrane attenuated ligand-induced c-Met activation and subsequent biological responses (Figure 4) . Thus, our data support the idea that endocytic trafficking of c-Met is a positive regulatory factor for its sustained signal transduction along with a series of reports supporting this opinion. First, the endocytic trafficking of c-Met mediated by PKCe induces sustained activation of Erk1/2, translocation of active Erk1/2 to focal-adhesion site, and consequently increased cell migration. 2, 36 In addition, PKCa regulates c-Met trafficking to the perinuclear region and active Met in endocytic vesicles mediates the nuclear accumulation of STAT3. 25 On top of that, c-Met triggers Ca 2 þ signaling by hydrolysis of phosphatidylinositol 4,5-bisphosphate and the formation of inositol 1,4,5-trisphosphate within the nucleus. 37 Finally, tumorassociated Met-activating mutations exhibited increased endocytic rate, which led to enhanced cell migration and neoplastic transformation. 38 Significantly, our data disclosed the underlying mechanism for these observations using 3S peptide; association between C-terminal dileucine motif and endocytic machinery including adaptin b and caveolin-1 acts to modulate c-Met trafficking and further phosphorylation-dependent c-Met signal transduction.
However, it is highly probable that the two contrasting effects of c-Met endocytosis on its signal transduction can coexist and even occur simultaneously in a cell. Cells might employ two different pathways to maintain cellular homeostasis in order to adapt to their ever-changing physiological environments such as ligand abundance, hypoxic condition, nutrient limitation and cell density. In case of EGFR, large amounts of EGFs render receptor 
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Role of dileucine motif in c-Met trafficking K-W Cho et al endocytosis to abate signaling, whereas endocytosis induced by scarce EGFs promotes sustained signaling by recruiting effector molecules to endosomal membrane. 1 For c-Met, it is unclear about the biological factors that determine the direction of signal transduction upon c-Met endocytosis. To investigate this, it is important to know about the intracellular mediators for c-Met trafficking. Our data suggest that endophilin-CIN85-Cbl complex is not only the mediator for c-Met endocytosis; adaptin b and caveolin-1 might function as mediators for c-Met trafficking towards signaling promotion. Therefore, it will be worthwhile to reveal the physiological factors that recruit preferentially one among endophilin-CIN85-Cbl complex, adaptin b and caveolin-1 to C-terminus of c-Met.
Even though we didn't cover such physiological determinants in our study, it is possible to propose the order of recruitment priority based on our co-immunoprecipitation data. As shown in Figure 4i , Ant-3S peptide, which blocked c-Met internalization, did not inhibit the recruitment of Cbl and CIN-85 to c-Met (Figure 4i ). This means that the interaction between endocytic machineries and 3S region is essential and prerequisite for c-Met endocytosis, rather than the association between Cbl and Y1003, Cbl-docking site. This is supported by Abella et al.
9 that ubiquitination-deficient Met mutant exhibited ligand-induced internalization at a similar rate to its wild type mutant.
In addition, an interesting finding was that the endocytosis of c-Met is simultaneously controlled by both clathrin-dependent and clathrin-independent pathways. Even though both adaptin b and caveolin-1 are involved in c-Met endocytosis, it is not yet known as to which one is a more critical mediator in c-Met trafficking for robust of downstream signaling. In terms of signaling promotion, defining differential roles of adaptin b and caveolin-1 in the c-Met internalization process would be an interesting field to study.
We supposed that 3S peptide could have an effect on the endocytosis of any receptors that have a dileucine motif in its cytosolic tail. To examine this hypothesis, we tested the effect of 3S peptide on Glut4, Glut8 and transferrin receptor. Unexpectedly, Ant-3S peptide was not able to block the endocytosis of Glut4 and Glut8 (Figure 5b ), even though they also have dileucine motif in their cytosolic tail like c-Met. More interestingly, our observation and Schmidt et al. 12 imply that c-Met and Glut8 share adaptin b through their dileucine motif during endocytosis. This suggests that endocytosis of each receptor is mediated by a different set of accessory components for delicate and selective sorting, and dileucine motif itself is insufficient for highly selective targeting. A series of reports indicate that dileucine motif has broad specificity 15 and thus has several binding partners: m subunits of AP-1, 2 and 3 for sorting of HIV-1 nef; 39 m2 during endocytosis of a 1b -adrenergic receptor; 40 g/s1 and s/s2 hemicomplexes for trafficking of LRP9. 13 With this view, we expect the profile of accessory proteins of c-Met, and those of Glut4 or Glut8 to be different from each other, even though some machinery such as adaptin b may be in common. In addition, each receptor has its own specific regulatory elements for distinct trafficking pathways. For example, Glut4 has another endosomal targeting motif distal to the dileucine signal. 41 Besides, Glut8 and Glut12 showed significant difference in trafficking from the plasma membrane even when they share in common a [DE]XXXL[LI] motif. 42 Moreover, Wang et al. 43 suggests that the interplay between a dileucine motif and the carboxyl tail of an opioid receptor mediates its lysosomal targeting. Altogether, cells employ specific accessory machineries and regulatory elements for the fine-tuning of diverse endocytic pathways.
In this regard, it would be a meaningful study to test if peptides, which contain shorter residues than 16 mer of 3S region, would work with the same efficiency as Ant-3S peptide. According to Stein et al., 27 surrounding residues contributed to the binding energy more, than 50% in some of the proteins such as adaptin N, Metallophos and Tsg101. But those of other proteins such as a adaptin C2, GYF and WH1 showed much less contributions as low as 4%. What about 3S peptide? Even though more investigations are required, our data suggest that the residues flanking the dileucine motif have an important role in specific binding with the endocytic machinery and further sorting; endocytosis of Glut4 and Glut8 other than IL2RA/3S was not affected by Ant-3S peptide, even though they also have a functional dileucine motif in their cytoplasmic tail like c-Met (Figure 5b ). Based on this result, we proposed that there is a high probability that peptides, which contain much shorter residues than 16 mer of 3S region, wouldn't work with the same efficiency as Ant-3S peptide. In other words, shorter length of 3S peptide might reduce the specificity to endocytic machinery such as adaptin b, caveolin1 and other putative binding partners. Other surrounding residues of dileucine motif would function for finetuning the directing of c-Met to various subcellular regions by affecting the conformational context of the binding moiety.
On the other hand, including more residues flanking the dilucine motif might increase the specificity. 27 However, longer peptides have higher possibility to have unexpected secondary structures. As far as 16-mer c-Met peptide is concerned, bioinformatics prediction by the program GOR IV 44 showed that it has a random coil owing to the presence of two prolines near dileucine motif (data not shown). In addition, the previous CD and nuclear magnetic resonance experiments showed that the structure of antennapedia-derived PTD is a random coil in water and it adopts a-helix in membrane-mimetic environments. 45, 46 Collectively, it is suggested that the 33-mer fusion peptide is largely unstructured in aqueous solution.
The use of short peptide is emerging as a platform for the treatment of cancer and transmittable disease. Although peptides account for only a small part of current therapeutic agents, their potential is being improved by new technologies affecting their modification, delivery, stability and their application in preclinical/clinical settings. 47 Particularly, small peptides including Cilengitide, ATN-161 (targeting integrin) and ABT-510 (targeting CD36) have been rigorously tested in phase I or II clinical stages for cancer therapeutics owing to their low toxicity and high specificity. 48 Ant-3S peptide's selective inhibitory property towards c-Met gives us the possibility of a c-Met-specific anti-cancer therapy. Targeted inhibition of endocytic motif in c-Met by Ant-3S peptide may be applied to the treatment of cancers that shows c-Met-dependent invasive growth. That's because, Met activation is closely related to the aggressiveness of intrinsic malignancy of transformed cells. Furthermore, the necessity of Met-targeting was emphasized by the failure of anti-angiogenic therapy; tumors gain resistance to antiangiogenic drugs and become more aggressive and metastatic. 49, 50 Therefore, combined treatment of anti-angiogenic drugs with Ant-3S peptide could be a meaningful challenge for the inhibition of cMet-driven aggravation of cancer progression. 
Generation of chimeric fusion proteins
Each cDNA was gifted from 21C Human Gene Bank, Genome Research Center, KRIBB, Korea, or amplified from human peripheral blood cDNA libraries. All DNA fragments were amplified by PCR and subcloned to pcDNA3.1 (-) vector (Invitrogen). Generation of HA-Glut4 and HA-Glut8 constructs has been described previously. 51, 52 DNA encoding HA-transferrin receptor was amplified by the following primers: Sense 5 0 -TT TTTTTCTAGAATGATGGATCAAGCTAGATCA-3 0 ; antisense 5 0 -TTTTTTGGAT CCTTAAGCGTAGTCTGGGACGTCGTATGGGTAAAACTCATTGTCAATGTCCCA AAC-3 0 (HA-epitope tag is underlined). This amplified DNA fragment was digested with XbaI/BamHI and subcloned to pcDNA3.1 (-) vector.
Immunofluorescence
Cells were plated onto a chamber slide (Nunc, Denmark) and incubated until they reached approximately 50% confluency. After endocytosis experiments, cells were fixed for 1 h in 4% paraformaldehyde/PBS and permeabilized in 0.2% Triton X-100 for 1 h. To block the background activity, 3% of normal goat serum was added during permeabilization. Then the cells were incubated with primary antibody (at 4 1C overnight) and subsequently with secondary antibody (at room temperature for 2 h). Cells were counterstained with DAPI (Sigma, St Louis, MO, USA) and imaged with Olympus IX2-UCB microscope (Olympus Corporation, Tokyo, Japan).
For immunofluorescence of IL2RA chimeric fusion proteins, following inhibitors were used: 100 mg/ml ConA, 80 mM Dynasore, 1 mM vinblastine (Sigma), and 1 mM K252a (Invitrogen). Each inhibitor was pre-treated onto cells for 30 min at 37 1C. Antibodies used in immunofluorescence were as follows: anti-IL2RA, anti-adaptin a, anti-adaptin b1/2 (BD bioscience, San Jose, CA, USA), anti-c-Met (R&D systems, Wiesbaden, Germany), anti-p-Met (Upstate, Lake Placid, NY, USA), anti-caveolin-1 (Santacruz Biotech, CA, USA), anti-HA, anti-rabbit IgG Alexa Fluor 568, anti-mouse IgG-Alexa Fluor 488, anti-mouse IgG-Alexa Fluor 568, and anti-goat IgG-Alexa Flour 568 (Invitrogen).
Co-immunoprecipitation
After serum starvation for 24 h, 293E cells were pre-incubated with vehicle, 3S peptide or nothing for 90 min. Then 20 ng/ml recombinant human HGF (R&D systems) were treated for 15 min and cells were lysed with NP-40 lysis buffer in the presence of protease-inhibitor cocktail (CalbioChem, San Diego, CA, USA). After pre-clearing with hIgG and protein G agarose bead (GE Healthcare, Piscataway, NJ, USA), anti-c-Met (B7, generated by phage display in our group) was used for immunoprecipitation.
Flow cytometry
After the treatment of Ant-3S peptide or vehicle at 37 1C, the cells were harvested. Cells were incubated with 2 mg/ml anti-c-Met (R&D systems) for 30 min on ice and then washed with ice-cold PBS and incubated with 4 mg/ml anti-goat IgG-Alexa Flour 568 (Invitrogen). Then cells were analyzed via flow cytometry using a FACSCANTO system with FACS DIVA software (BD Pharmingen, San Diego, CA, USA). Representative graphs were generated with FlowJo software.
Western blot
After serum starvation for 24 h, the cells were pre-treated with vehicle, peptide and inhibitors including 500 nM PHA-665752, 500 nM Wortmannin (Calbiochem), 80 mM Dynasore and 10 nM GM6001 (Sigma) for 90 min at 37 1C. The cells were lysed with RIPA buffer, supplemented with PMSF, phosphatase-inhibitor cocktail (Sigma) and protease-inhibitor cocktail on ice for 1 h and the lysates were clarified by centrifugation. Equal amounts of lysates were subjected to SDS--PAGE, transferred onto a nitrocellulose membrane, and blocked for 1 h at room temperature in Tris--buffered saline with 0.05% Tween-20 (TBST) and 5% non-fat milk. The membrane was subsequently incubated with anti-p-Met (Invitrogen), anti-c-Met (R&D systems), anti-b-actin (Sigma), anti-pErk1/2, anti-pAKT (Cell Signaling, Danvers, MA, USA), anti-GAPDH (Milipore, Billerica, MA, USA), anti-cbl, anti-caveolin-1 (Santacruz Biotech) and anti-CIN85 (Upstate) at 4 1C overnight. After washing with TBST, blots were incubated with the appropriate secondary antibodies for 1 h at room temperature and developed using ECL detection reagent (Intron Biotechnology, Seoul, Korea).
MTT assay
Hep3B cells were seeded onto 96-well Maxisorp plates (NUNC) at 5 Â 10 3 cells/well. After serum starvation for 24 h, cells were pre-incubated with vehicle or Ant-3S-peptide for 90 min. Then, cells were grown in DMEM/2% FBS in the presence or absence of 40 ng/ml HGF. After 72 h, 0.5 mg/ml of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma) was added and cells were incubated for 2 h at 37 1C. Absorbance at 570 nm was measured following the solubilization of crystals with dimethyl sulfoxide. Measurements from triplicates were expressed as a percentage of growth stimulation by HGF.
Wound healing assay
Hep3B cells were grown to 95% confluency in 6-well plates (Costar, Corning, NY, USA). After serum starvation for 24 h, the monolayer of cells was wounded by making straight scratches with a sterile 10 ml micropipette tip. Cells were washed with PBS, and pre-treated with vehicle or 0.1 mM Ant-3S peptide for 90 min at 37 1C. Then, the complete medium containing 40 ng/ml of HGF was added. After 24 h, the cells were photographed under X 20 objective lens.
Madin--darby canine kidney (MDCK) cell scattering assay MDCK cells were plated onto a 24-well plate (Costar) at 1 Â 10 4 cell/ml. Next day, cells were pre-incubated with vehicle or 0.1 mM Ant-3S peptide for 90 min, then stimulated with 20 ng/ml HGF. After 16 h, cells were photographed under X 20 objective lens.
Migration assay
Cells were plated in 100 ml DMEM containing 0.1 mM. Ant-3S peptide, vehicle or nothing on 24-well Transwell inserts (Costar). The underside of the inserts was pre-coated with fibronectin (BD bioscience). After incubation for 90 min at 37 1C or 5% CO 2 , upper chambers were assembled onto the lower chambers, which contain 500 ml DMEM/10% FBS containing 20 ng/ml HGF. After 24 h, the inserts were fixed and stained using Diffquick stain kit (Sysmex, Kobe, Japan).
Statistical analysis of immunofluorescence images
To quantify endocytosis of IL2RA chimeric fusion proteins in COS-7, the following formula was used.
%Surface IL2RA¼ Surface IL2RA Total IL2RA Â100 ¼ Green Green þ RedÀa Ã Â100 Ã a: Partial surface IL2RA measured by Red fluorescence To detect the surface IL2RA, we labeled IL2RA with anti-mouse IgG-Alexa Fluor 488 before permeablization, whereas intracellular IL2RA were labeled with anti-mouse IgG-Alexa Fluor 568 after permeablization. As such, greenfluorescence intensity indicates the amount of cell surface IL2RA and redfluorescence intensity signifies those of endocytosed IL2RA plus partial cell surface IL2RA. As the two secondary Abs used in the experiment are different polyclonal Abs from each other, detection of surface IL2RA by the latter labeling with anti-mouse IgG-Alexa Fluor 568 may have been partially inhibited by the former labeling with anti-mouse IgG-Alexa Fluor 488. To counterbalance this inhibitory effect, partially detected surface IL2RA by anti-mouse IgG-Alexa Fluor 568 was calculated based on the difference of fluorescence intensity between green and red at 0 min in which we assume that percentage of surface IL2RA is 100%. Redfluorescence intensity was 0.429-fold of green fluorescence intensity at 0 min, which means that 42.9% of surface IL2RA was detected by antimouse IgG-Alexa Fluor 568. This partial cell surface IL2RA measured by anti-mouse IgG-Alexa Fluor 568 was defined as a.
